GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Abbisko Cayman Ltd (HKSE:02256) » Definitions » Total Stockholders Equity

Abbisko Cayman (HKSE:02256) Total Stockholders Equity : HK$2,166.89 Mil (As of Dec. 2023)


View and export this data going back to 2021. Start your Free Trial

What is Abbisko Cayman Total Stockholders Equity?

Abbisko Cayman's Total Stockholders Equity for the quarter that ended in Dec. 2023 was HK$2,166.89 Mil. It refers to the net assets owned by shareholders. It does not include minority interest.

Total Stockholders Equity is used to calculate Book Value per Share. Abbisko Cayman's Book Value per Share for the quarter that ended in Dec. 2023 was HK$3.34. The ratio of a company's debt over equity can be used to measure how leveraged this company is. Abbisko Cayman's Debt-to-Equity for the quarter that ended in Dec. 2023 was 0.02.


Abbisko Cayman Total Stockholders Equity Historical Data

The historical data trend for Abbisko Cayman's Total Stockholders Equity can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Abbisko Cayman Total Stockholders Equity Chart

Abbisko Cayman Annual Data
Trend Dec19 Dec20 Dec21 Dec22 Dec23
Total Stockholders Equity
-510.78 -1,309.89 3,105.32 2,620.25 2,166.89

Abbisko Cayman Semi-Annual Data
Dec19 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23
Total Stockholders Equity Get a 7-Day Free Trial 3,105.32 2,908.91 2,620.25 2,441.28 2,166.89

Abbisko Cayman  (HKSE:02256) Total Stockholders Equity Explanation

1. Total Stockholders Equity is used to calculate Book Value per Share.

Abbisko Cayman's Book Value per Share for the quarter that ended in Dec. 2023 is

2. The ratio of a company's debt over equity can be used to measure how leveraged this company is.

Abbisko Cayman's Debt-to-Equity for the quarter that ended in Dec. 2023 is

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Abbisko Cayman Total Stockholders Equity Related Terms

Thank you for viewing the detailed overview of Abbisko Cayman's Total Stockholders Equity provided by GuruFocus.com. Please click on the following links to see related term pages.


Abbisko Cayman (HKSE:02256) Business Description

Traded in Other Exchanges
Address
Building 3, No. 898 Halei Road, Zhangjiang Hi-Tech Park, Pudong New Area, Shanghai, CHN
Abbisko Cayman Ltd is a investment holding company it operates through its subsidiaries which is a clinical-stage biopharmaceutical company dedicated to the discovery and development of innovative and differentiated small molecule oncology therapies. The company has only one business segment which is the development of innovative medicines.

Abbisko Cayman (HKSE:02256) Headlines

No Headlines